These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2492146)

  • 1. Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy.
    Check JH; Chase JS; Spence M
    Am J Obstet Gynecol; 1989 Jan; 160(1):114-5. PubMed ID: 2492146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives.
    Benadiva CA; Ben-Rafael Z; Blasco L; Tureck R; Mastroianni L; Flickinger GL
    Fertil Steril; 1988 Sep; 50(3):516-8. PubMed ID: 3137106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible busulfan-induced ovarian failure.
    Shalev O; Rahav G; Milwidsky A
    Eur J Obstet Gynecol Reprod Biol; 1987 Nov; 26(3):239-42. PubMed ID: 2828130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amenorrhea following use of combined oral contraceptives.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1973; 52(4):373-9. PubMed ID: 4271880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA; Brenner PF; Kletzky OA; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of gonadotropin-releasing hormone analog and human menopausal gonadotropins for ovulation induction in premature ovarian failure.
    Letterie G; Miyazawa K
    Acta Obstet Gynecol Scand; 1989; 68(6):571-3. PubMed ID: 2520819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of Kaufmann therapy and large dose treatment of human menopausal gonadotropin on gonadotropin resistant ovary syndrome (author's transl)].
    Utsunomiya T; Yamaguchi S; Yoshida K; Tateyama H; Katagiri H; Kadota T
    Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):250-8. PubMed ID: 6785987
    [No Abstract]   [Full Text] [Related]  

  • 11. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    J Assist Reprod Genet; 1998 Nov; 15(10):599-604. PubMed ID: 9866068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary estrogen and serum gonadotropin profiles in women ingesting oral contraceptive steroid formulations with variable estrogen content.
    Grimes EM; Thompson IE; Taymor ME
    J Natl Med Assoc; 1983 Jun; 75(6):575-80. PubMed ID: 6410078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous and pharmacologically induced remissions in patients with premature ovarian failure.
    Kreiner D; Droesch K; Navot D; Scott R; Rosenwaks Z
    Obstet Gynecol; 1988 Dec; 72(6):926-8. PubMed ID: 3141855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrinological studies in two patients with post contraceptive cyclic dysfunction.
    Adamopoulos DA; Loraine JA; Ginsburg J; Loudon NB
    Scott Med J; 1972 Aug; 17(8):270-4. PubMed ID: 4642685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone-sparing properties of oral contraceptives.
    DeCherney A
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):15-20. PubMed ID: 8571999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected pregnancy during hormone-replacement therapy in a woman with elevated follicle-stimulating hormone levels and amenorrhea.
    Laml T; Huber JC; Albrecht AE; Sintenis WA; Hartmann BW
    Gynecol Endocrinol; 1999 Apr; 13(2):89-92. PubMed ID: 10399052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of the pituitary-ovarian axis to pulsatile administration of gonadotropin-releasing hormone in long-term oral contraceptive users.
    Hemrika DJ; Slaats EH; Schoemaker J
    Am J Obstet Gynecol; 1994 Feb; 170(2):462-8. PubMed ID: 8116698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovulation after treatment with ethinyl-oestradiol and medroxyprogesterone acetate in a woman approaching premature menopause. Case report.
    Petsos P; Buckler H; Mamtora H; Anderson DC
    Br J Obstet Gynaecol; 1986 Nov; 93(11):1155-60. PubMed ID: 3096369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.